dysregul
renin
angiotensin
system
ra
consid
major
factor
develop
cardiovascular
patholog
within
ra
angiotensinconvert
enzym
ace
convert
angiotensin
ang
vasoconstrictor
ang
ii
regul
saltwat
homeostasi
vasoconstrict
modul
blood
pressur
also
implic
inflamm
endotheli
dysfunct
oxid
stress
counterregulatori
arm
ra
known
exist
novel
ace
homolog
bind
ma
receptor
masr
metabol
ang
ang
ii
inact
ang
well
ang
addit
ang
also
directli
gener
ang
cleavag
ace
gener
ang
exert
varieti
cardioprotect
effect
mani
opposit
attribut
ang
ii
wide
distribut
express
abund
heart
blood
vessel
kidney
exert
import
action
cardiac
function
blood
pressur
ang
mainli
form
oppos
mani
ang
action
ang
also
shown
benefici
biolog
effect
via
ang
ii
type
receptor
result
cardioprotect
sever
line
evid
show
role
ma
axi
atherosclerosi
protein
express
endotheli
cell
smooth
muscl
cell
macrophag
aortic
coronari
atherosclerot
lesion
overexpress
significantli
inhibit
earli
atherosclerot
lesion
develop
human
endotheli
cell
vitro
apoedefici
mice
vivo
similar
antiatherosclerot
effect
seen
rabbit
atherosclerosi
model
addit
overexpress
attenu
progress
lesion
stabil
atherosclerot
plaqu
rabbit
form
endotheli
injuri
atherogen
diet
convers
genet
defici
significantli
increas
accumul
atherosclerot
plaqu
via
upregul
put
mediat
atherogenesi
enhanc
respons
proinflammatori
stimuli
differenti
regul
activ
progress
atherosclerosi
report
enzymat
activ
lower
stabl
advanc
atherosclerot
lesion
compar
earli
ruptur
atherosclerot
lesion
similar
atheroprotect
ang
shown
mani
previou
studi
level
ang
elev
late
atherosclerot
plaqu
apoeknockout
mice
endogen
activ
ang
play
protect
effect
atherosclerot
plaqu
instabl
longterm
ang
treatment
caus
reduct
lesion
progress
mous
model
atherosclerosi
improv
endotheli
function
moreov
ang
dose
depend
inhibit
earli
atherosclerot
lesion
via
suppress
vascular
smooth
muscl
cell
prolifer
migrat
larg
dose
ang
enhanc
plaqu
stabil
via
inhibit
plaqu
inflamm
mention
role
ma
axi
pathogenesi
atherosclerosi
investig
use
variou
anim
model
studi
focus
much
known
regard
role
ang
ang
coronari
atherosclerosi
clinic
studi
confirm
link
circul
level
ma
axi
coronari
atherosclerosi
human
thu
aim
present
studi
examin
associ
circul
level
ang
ang
coronari
heart
diseas
chd
defin
coronari
angiographi
cag
consecut
patient
underw
cag
evalu
suspect
chd
cardiolog
depart
guangdong
provinci
peopl
hospit
enrol
present
studi
chd
defin
signific
coronari
stenosi
least
one
major
coronari
arteri
follow
world
health
organ
criteria
assess
use
cag
subject
show
prior
percutan
surgic
coronari
revascular
accord
subject
divid
two
group
chd
group
diamet
narrow
n
nonchd
group
diamet
narrow
n
major
exclus
criteria
includ
congest
heart
failur
clinic
import
cardiac
arrhythmia
valvular
heart
diseas
ongo
system
inflammatori
diseas
renal
hepat
dysfunct
malign
diseas
use
drug
may
influenc
ra
hormon
level
direct
renin
inhibitor
dri
ace
inhibitor
acei
ang
ii
receptor
blocker
arb
aldosteron
antagonist
aa
pregnanc
lactat
women
patient
unwilling
particip
survey
patient
underw
cag
via
femor
radial
arteri
standard
method
angiogram
evalu
two
experienc
cardiologist
blind
data
sever
chd
assess
number
stenot
coronari
vessel
singlevessel
diseas
defin
stenosi
one
major
epicardi
arteri
import
branch
major
epicardi
coronari
arteri
multivessel
coronari
diseas
mean
presenc
stenosi
two
major
epicardi
arteri
left
main
coronari
arteri
syntax
score
system
util
quantifi
complex
chd
coronari
lesion
diamet
stenosi
vessel
mm
score
use
onlin
syntax
score
calcul
version
wwwsyntaxscorecom
cutoff
use
current
useuropean
guidelin
patient
low
lesion
complex
syntax
score
intermedi
lesion
complex
defin
syntax
score
high
lesion
complex
defin
syntax
score
analys
perform
use
ibm
spss
statist
softwar
version
ibm
corp
armonk
ny
continu
variabl
express
mean
standard
deviat
sd
median
interquartil
rang
categor
variabl
percentag
chi
squar
test
standard
oneway
analysi
varianc
anova
test
use
comparison
categor
continu
variabl
respect
univari
multivari
logist
regress
analys
perform
determin
factor
associ
chd
divid
distribut
paramet
quartil
odd
ratio
confid
interv
ci
calcul
relat
quartil
increas
level
univari
associ
covari
chd
indic
supplementari
tabl
variabl
p
valu
univari
analysi
enter
multivari
analysi
previou
studi
report
diabet
close
associ
chd
thu
diabet
enter
multivari
analysi
estim
use
sever
logist
regress
model
progress
adjust
model
unadjust
model
adjust
age
diabet
model
adjust
sbp
sodium
fbg
hdlc
consid
p
valu
less
signific
test
clinic
biochem
characterist
studi
subject
includ
angiographi
confirm
chd
patient
nonchd
patient
present
tabl
subject
chd
tend
men
older
higher
potassium
fbg
level
develop
chd
serum
sodium
hdlc
level
chd
patient
lower
nonchd
patient
clinic
characterist
compar
chd
patient
nonchd
patient
shown
fig
male
significantli
higher
male
vs
femal
vs
pgml
p
ang
male
vs
femal
vs
pgml
p
activ
lower
ang
male
vs
femal
vs
pgml
p
level
femal
thu
betweengroup
comparison
perform
separ
male
femal
circul
level
increas
femal
chd
patient
compar
nonchd
patient
vs
pgml
p
fig
ang
ang
level
signific
differ
two
group
fig
c
also
signific
differ
circul
ang
ang
level
male
patient
without
chd
fig
circul
level
divid
quartil
categori
calcul
ci
use
multipl
logist
regress
analysi
evalu
predictor
chd
studi
popul
tabl
quartil
significantli
associ
chd
femal
p
trend
compar
peopl
lowest
quartil
highest
quartil
ci
chd
adjust
age
diabet
sbp
sodium
fbg
hdlc
model
ci
third
quartil
ci
highest
quartil
p
trend
studi
subject
divid
three
group
accord
number
diseas
coronari
arteri
nonchd
singl
vessel
multivessel
stratifi
three
group
base
syntax
score
low
score
intermedi
score
high
score
signific
differ
found
multivessel
lesion
group
nonchd
group
p
group
p
fig
circul
level
correl
complex
atherosclerosi
assess
syntax
score
p
fig
studi
character
first
time
level
ma
axi
patient
chd
demonstr
gender
differ
circul
level
ma
axi
perform
sexspecif
analys
femal
circul
level
higher
chd
group
nonchd
group
multivari
logist
regress
analys
show
independ
associ
chd
howev
circul
ang
ang
level
compar
two
group
male
level
ma
axi
signific
differ
chd
patient
nonchd
patient
gene
locat
x
chromosom
convert
ang
ang
ii
ang
ang
reason
gender
differ
ma
axi
studi
healthi
individu
subject
type
diabet
renal
diseas
demonstr
male
trend
higher
activ
femal
result
accord
previou
find
higher
serum
activ
male
femal
renal
cortic
ang
level
higher
femal
spontan
hypertens
rat
compar
male
rat
studi
involv
healthi
subject
report
women
exhibit
higher
plasma
concentr
ang
compar
men
contrast
result
previou
studi
involv
healthi
subject
show
men
significantli
higher
circul
ang
level
women
first
examin
influenc
gender
circul
level
ang
patient
without
chd
result
show
level
ang
men
higher
women
higher
level
ang
men
might
link
increas
could
promot
ang
format
ang
ii
one
first
studi
demonstr
circul
level
ang
higher
femal
specul
higher
ang
level
femal
may
result
increas
activ
ang
compon
directli
convert
ang
ang
therefor
although
inconsist
result
gender
differ
ma
axi
exist
may
mediat
part
sex
hormon
exampl
estrogen
demonstr
associ
nonclass
ra
compon
includ
ang
masr
activ
addit
gender
differ
present
preval
clinic
outcom
chd
known
exist
thu
perform
sexspecif
analys
subsequ
larger
popul
studi
need
investig
determin
whether
associ
axi
chd
vari
accord
gender
cleavag
catalyt
activ
ectodomain
result
smaller
protein
fragment
found
plasma
serum
urin
known
solubl
circul
activ
consid
marker
cardiovascular
diseas
cvd
low
level
healthi
individu
increas
level
cvd
hypertens
heart
failur
myocardi
infarct
major
find
present
studi
circul
level
increas
femal
angiograph
proven
chd
patient
suggest
activ
may
serv
novel
marker
chd
women
studi
involv
subject
type
diabet
circul
level
significantli
higher
histori
chd
seem
combat
advers
effect
activ
ra
therefor
may
compensatori
mechan
coronari
atherosclerosi
previou
studi
shown
express
cardiac
increas
myocardi
infarct
mi
circul
activ
also
significantli
increas
mi
patient
anim
model
result
suggest
even
though
without
acut
myocardi
injuri
increas
circul
may
reflect
coronari
underli
atherosclerosi
rather
mi
howev
associ
chd
found
men
sex
dimorph
chd
observ
preval
onset
age
chd
estrogen
thought
benefici
effect
atherosclerot
plaqu
progress
vasodil
blood
pressur
prior
menopaus
women
rel
protect
chd
compar
men
age
rang
onset
age
chd
women
typic
year
later
men
therefor
gener
consid
male
risk
factor
chd
interestingli
serum
level
associ
chd
women
studi
sever
mechan
may
explain
serum
greater
rel
risk
chd
women
men
first
studi
show
differ
baselin
level
age
sbp
sodium
fbg
hdlc
among
particip
without
chd
significantli
greater
women
men
supplementari
tabl
tabl
sex
differ
chd
risk
relat
level
may
mediat
part
differ
level
cardiovascular
risk
factor
moreov
women
found
longer
time
symptom
onset
diagnosi
intervent
less
like
receiv
proven
efficaci
therapi
aspirin
statin
thrombolyt
less
like
refer
invas
test
coronari
arteri
bypass
graft
treatment
bia
favor
men
may
caus
excess
rel
risk
chd
women
higher
level
adjust
confound
factor
risk
develop
chd
remain
significantli
higher
highest
circul
level
quartil
group
lowest
quartil
group
woman
indic
first
time
circul
level
independ
predict
develop
chd
woman
subject
withinchd
group
analysi
show
multivessel
lesion
group
singlevessel
lesion
group
significantli
higher
nonchd
group
result
indic
independ
associ
chd
femal
patient
connect
multivessel
lesion
syntax
score
use
score
complex
chd
signific
correl
circul
level
syntax
score
chd
patient
found
studi
suggest
circul
activ
act
marker
evalu
complex
chd
summari
find
demonstr
increas
independ
associ
chd
femal
patient
multivessel
lesion
even
adjust
confound
factor
result
reinforc
import
counterregulatori
role
coronari
atherosclerosi
thu
modul
could
offer
futur
therapeut
option
patient
atherosclerot
diseas
undergo
shed
releas
catalyt
activ
ectodomain
extracellular
milieu
process
result
detect
circul
shed
membranebound
stimul
disintegrin
metalloproteinas
known
tumor
necrosi
enzym
tace
may
aberr
neoexpress
endotheli
cell
patholog
condit
certain
condit
mi
kidney
diseas
diabet
abnorm
express
endotheli
protein
could
shed
circul
thu
could
sourc
increas
circul
activ
previou
studi
show
tissu
activ
humanruptur
atherosclerot
lesion
increas
compar
stabl
advanc
atherosclerot
lesion
suggest
circul
level
higher
femal
chd
patient
without
chd
circul
level
associ
tissu
express
result
support
increas
circul
level
reflect
increas
tissu
synthesi
mrna
increas
shed
protein
studi
simultan
measur
tissu
circul
activ
need
mention
ang
ang
propos
import
mediat
cardioprotect
seri
studi
demonstr
plasma
myocardi
tissu
level
ang
significantli
increas
myocardi
infarct
contrast
anoth
studi
indic
circul
level
ang
ang
level
increas
week
myocardi
infarct
latter
observ
consist
find
circul
ang
level
increas
chd
patient
differ
signific
ang
prove
protect
factor
atherosclerosi
action
mainli
opposit
ang
ii
includ
antifibrot
antitrop
action
heart
vasodil
antiprolifer
effect
blood
vessel
demonstr
plasma
level
ang
significantli
chang
patient
noncrit
coronari
atherosclerosi
moreov
patient
sever
coronari
atherosclerosi
ang
level
elev
thu
believ
ang
might
compensatori
mechan
develop
human
atherosclerosi
clinic
strategi
evalu
circul
ang
coronari
atherosclerosi
need
confirm
conclus
data
suggest
chang
level
ang
two
group
littl
known
regard
role
ang
may
act
intermedi
involv
format
ang
ang
whether
ang
direct
biolog
effect
cardiac
action
gener
differ
metabolit
still
open
question
one
first
studi
demonstr
level
ang
ang
parallel
increas
serum
level
patient
suspect
chd
suggest
increas
activ
might
directli
affect
atherosclerosi
progress
rather
induc
convers
ang
ii
ang
ang
ang
sever
limit
consid
first
singlecent
studi
involv
rel
small
number
patient
studi
larger
sampl
size
need
perform
second
patient
chd
higher
percentag
compar
nonchd
group
led
differ
number
two
group
third
crosssect
studi
limit
conclus
causal
associ
longterm
followup
may
strengthen
conclus
final
simultan
measur
tissu
circul
level
ma
axi
thu
fail
identifi
hypothes
increas
tissu
ma
result
increas
circul
ma
activ
moreov
mechan
regul
chd
human
need
determin
via
basic
research
conclus
present
studi
provid
novel
inform
ma
axi
chd
curat
level
ang
ang
level
significantli
increas
femal
chd
group
compar
nonchd
group
subgroup
analysi
show
signific
differ
exist
patient
multivessel
lesion
increas
independ
associ
chd
femal
adjust
confound
factor
find
support
circul
level
may
potenti
biomark
chd
direct
cardiovascular
protect
thu
modul
could
offer
futur
therapeut
option
patient
atherosclerot
diseas
